DK2029554T3 - Pyrazinderivater og anvendelser heraf til nyreovervågning - Google Patents

Pyrazinderivater og anvendelser heraf til nyreovervågning

Info

Publication number
DK2029554T3
DK2029554T3 DK07809706.0T DK07809706T DK2029554T3 DK 2029554 T3 DK2029554 T3 DK 2029554T3 DK 07809706 T DK07809706 T DK 07809706T DK 2029554 T3 DK2029554 T3 DK 2029554T3
Authority
DK
Denmark
Prior art keywords
applications
pyrazine derivatives
renal monitoring
renal
monitoring
Prior art date
Application number
DK07809706.0T
Other languages
English (en)
Inventor
William L Neumann
Raghavan Rajagopalan
Richard B Dorshow
Original Assignee
Medibeacon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibeacon Llc filed Critical Medibeacon Llc
Application granted granted Critical
Publication of DK2029554T3 publication Critical patent/DK2029554T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK07809706.0T 2006-06-22 2007-06-20 Pyrazinderivater og anvendelser heraf til nyreovervågning DK2029554T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81571206P 2006-06-22 2006-06-22
PCT/US2007/014370 WO2007149479A1 (en) 2006-06-22 2007-06-20 Pyrazine derivatives and uses thereof in renal monitoring

Publications (1)

Publication Number Publication Date
DK2029554T3 true DK2029554T3 (da) 2014-06-10

Family

ID=38577613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07809706.0T DK2029554T3 (da) 2006-06-22 2007-06-20 Pyrazinderivater og anvendelser heraf til nyreovervågning

Country Status (10)

Country Link
US (6) US8115000B2 (da)
EP (1) EP2029554B1 (da)
JP (1) JP2009534396A (da)
CN (1) CN101351454A (da)
AU (1) AU2007261398A1 (da)
CA (1) CA2628661A1 (da)
DK (1) DK2029554T3 (da)
ES (1) ES2456042T3 (da)
IL (1) IL189221A0 (da)
WO (1) WO2007149479A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2456042T3 (es) * 2006-06-22 2014-04-21 Medibeacon, LLC Derivados de pirazina y usos de los mismos en la monitorización renal
WO2007149478A2 (en) * 2006-06-22 2007-12-27 Mallinckrodt Inc. Pyrazine derivatives with extended conjugation and uses thereof
WO2008108944A2 (en) * 2007-03-01 2008-09-12 Mallinckrodt Inc. Integrated photoactive small molecules and uses thereof
WO2009061473A2 (en) * 2007-11-07 2009-05-14 Mallinckrodt Inc. Photonic shell-core cross linked and functionalized nanostructures for biological applications
CA2641297A1 (en) * 2008-07-11 2010-01-11 Richard B. Dorshow Pyrazine derivatives, methods of use, and methods for preparing same
US8697033B2 (en) 2008-12-17 2014-04-15 Medibeacon, LLC Modified pyrazine derivatives and uses thereof
US9433700B2 (en) 2009-04-27 2016-09-06 Medibeacon Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
CN103002921A (zh) 2010-05-14 2013-03-27 马林克罗特有限公司 用于联合的光学成像和治疗的功能***联纳米结构
US11077211B2 (en) 2013-11-11 2021-08-03 Medibeacon Inc. Compositions and methods for assessing gut function
HUE045725T2 (hu) 2014-02-13 2020-01-28 Incyte Corp Ciklopropilaminok mint LSD1 inhibitorok
ES2672797T3 (es) 2014-02-13 2018-06-18 Incyte Corporation Ciclopropilaminas como inhibidores de LSD1
ES2760261T3 (es) 2014-02-13 2020-05-13 Incyte Corp Ciclopropilaminas como inhibidores de LSD1
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007736A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyrazines as lsd1 inhibitors
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
MX2017012699A (es) 2015-04-03 2018-02-09 Incyte Corp Compuestos heterociclicos como inhibidores de demetilasa 1 especifica de lisina (lsd1).
JP6560766B2 (ja) * 2015-05-12 2019-08-14 メディビーコン，インク． 目の血管系を評価するための組成物及び方法
KR20180051523A (ko) 2015-08-12 2018-05-16 인사이트 코포레이션 Lsd1 저해제의 염
SG11201809299QA (en) 2016-04-22 2018-11-29 Incyte Corp Formulations of an lsd1 inhibitor
RU2721652C1 (ru) 2017-01-30 2020-05-21 Медибикон Инк. Способ неинвазивного мониторинга флуоресцентного индикаторного агента с меченым атомом с коррекциями диффузионного отражения
IL269617B1 (en) 2017-10-27 2024-05-01 Medibeacon Inc Compositions and systems for determining renal activity
EP3700579A4 (en) * 2017-10-27 2021-07-21 MediBeacon Inc. PROCEDURE FOR DETERMINING RENAL FUNCTION
BR112019021044A2 (pt) 2017-11-20 2020-05-12 Medibeacon Inc. Método para preparação e análise de compostos fluorescentes em plasma
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
WO2020122998A1 (en) * 2018-12-12 2020-06-18 Medibeacon Inc. Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy
WO2020149885A1 (en) * 2019-01-16 2020-07-23 Medibeacon Inc. Two piece sensor assembly and method of use
CA3125975A1 (en) 2019-01-28 2020-08-06 Medibeacon Inc. Systems and methods for home transdermal gfr monitoring
WO2023016483A1 (zh) * 2021-08-11 2023-02-16 杭州中美华东制药有限公司 制备作为荧光示踪剂的吡嗪羧酸类衍生物的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39114A0 (en) 1971-04-13 1972-05-30 Du Pont Novel cyanopyrazines carbamoyl diaminopyrazines,and 3,5-diaminopyrazinoic acid,and their preparation
US3948895A (en) 1971-09-28 1976-04-06 E. I. Du Pont De Nemours And Company Synthesis of 3,5-diaminopyrazinoic acid from 3,5-diamino-2,6-dicyanopyrazine and intermediates
US3814757A (en) 1971-04-13 1974-06-04 Du Pont Diamino substituted dicyano pyrazines and process
US3808209A (en) 1972-07-14 1974-04-30 Du Pont Tetraaminopyrazine,2,3,5-triamino-6-nitropyrazine,2,6-diamino-3,5-dinitropyrazine
US4517186A (en) 1982-09-30 1985-05-14 Merck & Co., Inc. 2-Amino-3,5-dicyano-6-(substituted)pyrazine antimicrobial compounds
KR910004673B1 (ko) 1986-08-13 1991-07-09 닛뽕소다 가부시끼가이샤 2,3-디아미노아크릴로니트릴 유도체
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
JPH0249775A (ja) 1988-05-19 1990-02-20 Nippon Soda Co Ltd ６員環又は７員環を有する複素環化合物及びその製造方法
JPH0217163A (ja) 1988-07-05 1990-01-22 Nippon Soda Co Ltd ジアミノマレオニトリル及びジアミノアクリロニトリル誘導体の製造方法
JPH0269457A (ja) 1988-09-06 1990-03-08 Nippon Soda Co Ltd ピロール誘導体及びその製造法
DE69014196T2 (de) * 1989-08-31 1995-03-30 Nippon Soda Co 3,6-diamino-2,5-pyrazindicarbonitril und ihre herstellung.
US5145610A (en) 1989-11-27 1992-09-08 E. I. Du Pont De Nemours And Company Organic optical elements and nonlinear optical devices
JPH04112877A (ja) 1990-09-04 1992-04-14 Nippon Soda Co Ltd 新規シアノピラジン誘導体及びその製造方法
EP0579835A4 (en) 1991-11-12 1994-06-01 Nippon Soda Co Wavelength conversion material for agriculture
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
JPH07149736A (ja) 1993-10-07 1995-06-13 Nippon Soda Co Ltd シアノピラジン誘導体および成形体
JPH07143168A (ja) 1993-11-19 1995-06-02 Hitachi Ltd ネットワークアドレス管理方式
JPH07278456A (ja) 1994-04-12 1995-10-24 Nippon Soda Co Ltd 蛍光着色剤
US5605809A (en) 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
JPH09143168A (ja) 1995-11-22 1997-06-03 Nippon Soda Co Ltd ２，３−ジアミノアクリロニトリル誘導体および３，６−ジアミノ−２，５−ピラジンジカルボニトリルの製造方法
JP3845848B2 (ja) 1996-01-25 2006-11-15 日本曹達株式会社 ２，３−ジアミノアクリロニトリル誘導体の製造方法
JPH09249773A (ja) 1996-03-19 1997-09-22 Nippon Soda Co Ltd 波長変換能を有するポリオレフィン系樹脂組成物、その組成物用マスターバッチおよびその組成物を含む農業用フイルム
JP3986587B2 (ja) 1996-07-30 2007-10-03 日本曹達株式会社 ピラジンジカルボン酸誘導体及びその製造方法
JP3666833B2 (ja) 1996-08-05 2005-06-29 株式会社リコー シート分離装置、これを用いた画像形成装置
ES2125817B1 (es) 1997-01-20 2000-01-01 Consejo Superior Investigacion Obtencion de nuevos cristales liquidos polimeros capaces de interaccionar con liposomas.
JP4153060B2 (ja) 1997-09-25 2008-09-17 日本曹達株式会社 ピラジン環を主鎖に有するポリエステル系化合物、その製造方法および高分子色素
NZ506051A (en) 1998-02-09 2003-08-29 Bracco Res S Targeted delivery of biologically active media
CA2340250A1 (en) 1998-08-20 2000-03-02 Kelley L. Ford Process for preparing regiospecific substituted pyrazine isomers
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US7556797B2 (en) 2000-10-16 2009-07-07 Mallinckrodt Inc. Minimally invasive physiological function monitoring agents
US6733744B1 (en) * 2000-10-16 2004-05-11 Mallinckrodt Inc. Indole compounds as minimally invasive physiological function monitoring agents
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
US6610322B1 (en) 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
JP2002212455A (ja) 2000-12-28 2002-07-31 Council Scient Ind Res 重ハロゲン原子で置換したスクアラインをベースとする色素とその調製方法およびその光線力学的な治療および工業用途の増感剤としての使用
JP4112877B2 (ja) 2001-03-09 2008-07-02 ダイセル化学工業株式会社 環状イミド系化合物で構成された触媒、及びこの触媒を用いた有機化合物の製造法
DE10222738A1 (de) 2002-05-23 2003-12-11 Johannes Wohlrab Ketoprofen-enthaltende Arzneiformulierungen zur Anwendung für die Photodynamische Therapie
JP2005304473A (ja) * 2004-03-24 2005-11-04 Nippon Soda Co Ltd 生体表面を着色する染色方法
CN101010107A (zh) * 2004-08-26 2007-08-01 马林克罗特公司 监测肾功能的发光金属络合物
WO2007106436A2 (en) 2006-03-10 2007-09-20 Mallinckrodt Inc. Photoactive compounds and compositions and uses thereof
JP2008525487A (ja) 2004-12-23 2008-07-17 マリンクロッド・インコーポレイテッド 蛍光ピラジン誘導体および腎機能評価におけるその使用方法
ES2456042T3 (es) * 2006-06-22 2014-04-21 Medibeacon, LLC Derivados de pirazina y usos de los mismos en la monitorización renal
CA2641297A1 (en) * 2008-07-11 2010-01-11 Richard B. Dorshow Pyrazine derivatives, methods of use, and methods for preparing same

Also Published As

Publication number Publication date
EP2029554A1 (en) 2009-03-04
US20140286874A1 (en) 2014-09-25
US9480687B2 (en) 2016-11-01
ES2456042T3 (es) 2014-04-21
CA2628661A1 (en) 2007-12-27
EP2029554B1 (en) 2014-03-19
US9114160B2 (en) 2015-08-25
US20090198053A1 (en) 2009-08-06
USRE47413E1 (en) 2019-06-04
CN101351454A (zh) 2009-01-21
JP2009534396A (ja) 2009-09-24
US20120100078A1 (en) 2012-04-26
IL189221A0 (en) 2008-06-05
US8115000B2 (en) 2012-02-14
US20150320745A1 (en) 2015-11-12
US8722685B2 (en) 2014-05-13
AU2007261398A1 (en) 2007-12-27
WO2007149479A1 (en) 2007-12-27
USRE47255E1 (en) 2019-02-26

Similar Documents

Publication Publication Date Title
DK2029554T3 (da) Pyrazinderivater og anvendelser heraf til nyreovervågning
DE602006011058D1 (de) Kontinuierliches backup
DK1984338T3 (da) Pyridylphenylforbindelser til inflammations- og immunrelaterede anvendelser
DK2089364T3 (da) Pyridinonforbindelser
DK1983954T3 (da) Fugtovervågningssystem til bleer og lignende
FI20060277A0 (fi) Kunnonvalvontajärjestelmä
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
DE602006019275D1 (de) Nitritnachweistechnik
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
NO20054709D0 (no) Sammenfoyningssystem og anvendelse av dette
DK2012773T3 (da) Lægemidler og anvendelser deraf
FI20061090A (fi) Kunnonvalvontamenetelmä
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2046802T3 (da) 2-substituerede methylpenamderivater
DK2185175T3 (da) MMP-9-regulatorer og anvendelser deraf
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
FI20060665A0 (fi) Poikkeavuuden havaitseminen
DK2188258T3 (da) Substituerede nikotinamidforbindelser og anvendelser deraf i lægemidler
FI20060906A0 (fi) Seurantajärjestelmä
BRPI0816288A2 (pt) Processos e compostos
DE602007009224D1 (de) R-cellular-systemen
FI20055349A0 (fi) Hälytinjärjestelmä